Literature DB >> 16728284

Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.

Phillip Scheinberg1, David A Price, David R Ambrozak, A John Barrett, Daniel C Douek.   

Abstract

OBJECTIVE: The selective elimination of alloreactive T cells from donor stem cell grafts prior to hematopoietic stem cell transplantation (HSCT) is an important goal in the prevention of graft-vs-host disease (GVHD). However, in HLA-identical donor-recipient pairs, it has proven difficult to identify alloreactive T cells using in vitro systems pretransplant due, in part, to their low frequency and a lack of methodological standardization. To better understand the alloresponse between HLA-identical related pairs, we characterized the alloreactive T cells generated in a mixed lymphocyte reaction (MLR) assay system.
METHODS: HSCT donor peripheral blood mononuclear cells (responder) were labeled with carboxyfluorescein diacetate, succinimidyl ester (CFSE) dye and cocultured with irradiated HSCT recipient cells (stimulator) in a one-way MLR. Alloreactive T cells were sorted by upregulation of activation markers (CD25 in most cases) and the responding clonotypes were defined by sequencing the complementarity region 3 (CDR3) of the T cell receptor beta-chain.
RESULTS: We show that the recruitment of alloreactive CD4(+) T cells is highly variable. Oligoclonal CD4(+) T-cell expansions in repeated MLRs performed in the same donor-recipient pair showed inconsistent recruitment of clonotypes. The recruitment of alloreactive CD8(+) T cells was more consistent in repeated assays, with the same clonotypes identified in the same donor-recipient pair performed under different conditions.
CONCLUSION: Taken together, our data show that even in culture conditions constrained to eliminate background proliferation, stochastic events and low precursor frequencies preclude reproducible elicitation of immunodominant T cell clonotypes with the potential to cause GVHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728284     DOI: 10.1016/j.exphem.2006.03.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Raising the spectra of T-cell profiling.

Authors:  William J Murphy
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

Review 2.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

3.  Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

Authors:  Stephan Mielke; Zachariah A McIver; Aarthy Shenoy; Vicki Fellowes; Hahn Khuu; David F Stroncek; Susan F Leitman; Richard Childs; Minoo Battiwalla; Eleftheria Koklanaris; Janice Haggerty; Bipin N Savani; Katie Rezvani; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-31       Impact factor: 5.742

4.  Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

Authors:  Zachariah A McIver; Jan J Melenhorst; Andrew Grim; Nicholas Naguib; Gerrit Weber; Vicki Fellowes; Hahn Khuu; David S Stroncek; Susan F Leitman; Minoo Battiwalla; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-30       Impact factor: 5.742

Review 5.  Nonhuman primate transplant models finally evolve: detailed immunogenetic analysis creates new models and strengthens the old.

Authors:  L S Kean; K Singh; B R Blazar; C P Larsen
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

Review 6.  A New Window into the Human Alloresponse.

Authors:  Susan DeWolf; Yufeng Shen; Megan Sykes
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.